Kaposi's sarcoma and disseminated tuberculosis in HIV-negative individual.

Idiopathic CD4 Lymphocytopenia: Spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med (2013) 1.34

Auricular involvement of a multifocal non-AIDS Kaposi's sarcoma: a case report. Acta Otorhinolaryngol Ital (2014) 0.75

Profound reduction of CD4+ lymphocytes without HIV infection: two cases from the horn of Africa. Afr Health Sci (2012) 0.75

Idiopathic CD4+ T-lymphocytopenia in two patients. CMAJ (1993) 0.75

"AIDS" without HIV: fire without smoke. BMJ (1992) 0.75

Community-based approaches to HIV treatment in resource-poor settings. Lancet (2001) 7.13

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group. N Engl J Med (1993) 4.88

Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (1999) 4.39

Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell (2001) 3.16

Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat (2009) 3.02

Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts. EMBO J (1998) 3.02

A Pluto-like radius and a high albedo for the dwarf planet Eris from an occultation. Nature (2011) 2.91

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients. Blood (2001) 2.82

Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations. Blood (1998) 2.60

Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses (1991) 2.52

European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47

Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med (1999) 2.39

Undergraduate education in emergency medicine. Ann Emerg Med (1990) 2.36

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A (2001) 2.27

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25

Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25

The proliferative potential of myeloma plasma cells manifest in the SCID-hu host. Blood (1999) 2.02

Remodelling of adipose tissue during experimental omental adhesion formation. Br J Surg (2008) 2.02

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00

Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). Proc Natl Acad Sci U S A (1989) 1.97

[Treatment and prophylaxis of the principal infections associated with the human immunodeficiency virus]. Med Clin (Barc) (1993) 1.96

Latex allergies in dentistry: recognition and recommendations. J Can Dent Assoc (1997) 1.95

Challenges to implementation of the new Coroners' (Amendment) Rules 2005: experience from a tertiary paediatric pathology centre. Med Sci Law (2007) 1.92

Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood (1999) 1.89

Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. Clin Infect Dis (2008) 1.86

Nonnucleoside human cytomegalovirus inhibitors: synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives. J Med Chem (2000) 1.86

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med (2008) 1.84

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol (2001) 1.83

Influence of digital and analogue cellular telephones on implanted pacemakers. Eur Heart J (1997) 1.82

Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis (1994) 1.82

A simple radioimmunoassay of plasma testosterone without column chromatography. Steroids (1974) 1.78

Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A (2001) 1.63

Selecting the future doctors: the role of graduate medical programmes. Intern Med J (2005) 1.61

Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation. J Interv Card Electrophysiol (1999) 1.60

Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry (1999) 1.60

Introduction of HIV drug-resistance testing in clinical practice. AIDS (1999) 1.58

Radiofrequency catheter ablation of idiopathic left ventricular outflow tract tachycardia: utility of intracardiac echocardiography. J Cardiovasc Electrophysiol (2001) 1.57

Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood (1996) 1.56

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS (2001) 1.56

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion (2000) 1.54

Characterization for enterotoxin production, virulence factors, and antibiotic susceptibility of Staphylococcus aureus isolates from various foods in Portugal. Food Microbiol (2009) 1.53

Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology (2000) 1.53

Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood (2000) 1.52

Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood (1994) 1.52

Emergency medicine--no longer a casualty. Med J Aust (1989) 1.50

The use of external data sources and ratio estimation to improve estimates of hardcore drug use from the NHSDA. NIDA Res Monogr (1997) 1.49

Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization. Allergy (2012) 1.48

Immunoglobulin G- and M-specific enzyme-linked immunosorbent assay for detection of dengue antibodies. J Clin Microbiol (1979) 1.48

Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47

Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Methods (2005) 1.45

[Strongyloidiasis and HTLV-I infection]. Med Clin (Barc) (1999) 1.44

The APC is dispensable for first meiotic anaphase in Xenopus oocytes. Nat Cell Biol (2001) 1.43

Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration. Eur Heart J (2000) 1.43

Increased emphasis of medically necessary oral health care. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.42

[Interferon in chronic hepatitis in patients infected by the human immunodeficiency virus: yes or no?]. Med Clin (Barc) (1992) 1.40

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.40

[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]. Med Clin (Barc) (1991) 1.40

[Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)]. Rev Esp Anestesiol Reanim (2002) 1.40

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J (2000) 1.40

Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol Cell Biol (2001) 1.40

[An esophageal ulcer due to cytomegalovirus in a female patient infected with the human immunodeficiency virus without serious immunosuppression: is this an acquired immunodeficiency syndrome?]. Med Clin (Barc) (1992) 1.40

Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds. Bioorg Med Chem Lett (1998) 1.40

High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood (2000) 1.39

[Complications in Mediterranean boutonneuse fever: prospective study of 78 patients]. Rev Clin Esp (1989) 1.39

[Antiretroviral treatment against HIV]. Med Clin (Barc) (1995) 1.39

HTLV-I and HTLV-II infections in Spain. Vox Sang (1993) 1.39

Multi-organ failure in a patient with sepsis due to Salmonella precipitated by liver trauma. Intensive Care Med (2000) 1.39

[Intensification of antiretroviral treatment]. Rev Clin Esp (2000) 1.39

Preventable death studies: an inappropriate tool for evaluating trauma systems. Aust N Z J Surg (1997) 1.39

Does care exclude cure in palliative care? J Palliat Care (1986) 1.38

[Retroviruses and autoimmune diseases]. Med Clin (Barc) (1993) 1.38

[Interrelationship between the duration of HIV infection, viral load and CD4 positive lymphocyte count]. Med Clin (Barc) (1998) 1.38

[Study of 164 episodes of infectious endocarditis in drug addicts: comparison of HIV positive and negative patients]. Rev Clin Esp (1994) 1.38

[Serologic activity against retrovirus in patients with Sjögren syndrome]. Med Clin (Barc) (1993) 1.38

Circulating hepatitis C virus genotypes in Spain. The Hepatitis/HIV Spanish Study Group. Vox Sang (1996) 1.38

[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]. Med Clin (Barc) (1996) 1.38

Comparison of the Serodia Treponema pallidum particle agglutination, Captia Syphilis-G, and SpiroTek Reagin II tests with standard test techniques for diagnosis of syphilis. J Clin Microbiol (2000) 1.36

Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group. AIDS (2000) 1.35

Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol (2000) 1.35

Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) (2009) 1.34

Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection. AIDS Res Hum Retroviruses (2005) 1.34

An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods (2001) 1.34

Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood (1993) 1.34

Higher efavirenz plasma levels correlate with development of insomnia. J Acquir Immune Defic Syndr (2001) 1.33